BPMC - Blueprint Medicines GAAP EPS of -$1.79 beats by $0.10 revenue of $62.73M beats by $22.75M May, 03 2022 07:16 AM Blueprint Medicines Corporation Blueprint Medicines press release (NASDAQ:BPMC): Q1 GAAP EPS of -$1.79 beats by $0.10. Revenue of $62.73M (+190.7% Y/Y) beats by $22.75M. For further details see: Blueprint Medicines GAAP EPS of -$1.79 beats by $0.10, revenue of $62.73M beats by $22.75M